Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mead Johnson seeks U.S. turnaround

This article was originally published in The Tan Sheet

Executive Summary

The nutritionals company relies on product launches and rebranding, along with packaging innovations, to reclaim market share in the U.S. from Abbott Nutrition. Net sales in North America and Europe during Mead Johnson's third quarter plummeted 16.5 percent to $286 million. The Glenview, Ill.-based company is introducing products in the U.S. at a record rate to compete with recent Abbott launches, "and we are beginning to see signs of stabilization," said CEO Stephen Golsby during an Oct. 22 earnings call. The firm's Asia/Latin America segment grew 4.9 percent with $413.8 million in net sales during the July-September period. Mead Johnson plans to expand distribution in China and establish a pediatric nutrition institute there, Golsby said. Abbott is developing a similar facility in Singapore (1"The Tan Sheet" March 2, 2009, In Brief). Additionally, Golsby said Mead Johnson has hired Tim Brown, formergeneral manager of Procter & Gamble's North America Personal Health Division, as general manager of its U.S. business

You may also be interested in...



Abbott puts the A in AMO

The Abbott Park, Ill.-based health care company completes its acquisition of Advanced Medical Optics - now Abbott Medical Optics - which is No. 3 in the contact lens care market, Abbott says Feb. 26. The European Commission gave the merger final clearance Feb. 20, Abbott says. Santa Ana, Calif.-based AMO reported net sales of $285.2 million, a drop of 6.4 percent, in its final independent fiscal quarter (1"The Tan Sheet" Feb. 23, 2009, In Brief). ... Similac in Singapore: Abbott opens its $300 million nutritional manufacturing facility, its single largest investment in Asia to date. Abbott says Feb. 26 it built the facility in response to increased demand for Similac and other pediatric nutritionals. The facility can serve up to 1 million Asian children annually (2"The Tan Sheet" April 24, 2006, p. 10). Abbott also plans to base a nutrition science research and development center in Singapore, the firm says

Ready, Set, Guidance: FDA Releases Final Details Ahead Of ASCA Pilot Launch

A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.

With Preservative-Free Alaway Eye Drops, Bausch Expands OTC Portfolio Of Planned Spin-Off

Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals. 

Topics

UsernamePublicRestriction

Register

MT142726

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel